Liraglutide Novo Nordisk

China OKs Novo Nordisk's Type-2 diabetes treatm...

Novo Nordisk hits all-time high as oral obesity...

Novo Nordisk - la compañia que trata la diabete...

Novo Nordisk Posts Record Growth as Demand For ...

Signal: Novo Nordisk market cap higher than Dan...

Novo Nordisk to test anti-obesity molecule in t...

Novo Nordisk

Novo Nordisk

Novo Nordisk's results are stunning - and it co...

Novo Nordisk leaps on new obesity drug data | p...

Is Novo Nordisk Stock a Buy After its Collapse?...

Novo Nordisk Logo Png

Novo Nordisk Logo Png

NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...

Novo Nordisk’s Global Commitment to Diabetes Ca...

First: Novo Nordisk India launches oral Semaglu...

Novo Nordisk amplía sus fármacos contra la obes...

Novartis' Sandoz dips on debut after lower than...

FID prosigue su larga colaboración con Novo Nor...

Novo Nordisk Research Centre opens in Oxford | ...

Novo Nordisk receives FDA approval for Wegovy™

Novo Nordisk launches once-a-week diabetes drug...

Novo Nordisk submits diabetes pill for US approval

Novo Nordisk A/S Sees Unusually Large Options V...

Novo Nordisk experience big profit rise due to ...